Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib in the FRESCO trial.
Qin S, Li J, Bai Y, Deng Y, Yang L, Xu RH, Zhong H, Chen Z, Pan H, Guo W, Shu Y, Xu J, Peng C, Chen Y, Li H, Wang N, Guo X, Peng M, Fan S, Shen L.
Qin S, et al. Among authors: li j, li h.
Future Oncol. 2021 May;17(15):1923-1931. doi: 10.2217/fon-2020-1215. Epub 2021 Feb 10.
Future Oncol. 2021.
PMID: 33563040